ThePharm
ActiveSummary
ThePharm has been active since 1968 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €268,374 and a net result of €112,397. Equity is shrinking by about 2.7% per year across the filed financial years. Its solvency ranks better than 59% of 12,724 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
24-04
Gazette deed
MiscellaneousCorrection2 facts ▸
- General meeting, 20-07-2023
- Correction, “last sentence”, 4 (deed in Dutch)
02-08
Gazette deed
Appointment: VINCENT DE MOOR (director)Amendment of the articles · Capital conversion · Registered office clause8 facts ▸
- General meeting, 20-07-2023
- Amendment of the articles (2 times)
- Capital conversion, “beschikbaar voor toekomstige uitkeringen” (deed in Dutch)
- Registered office clause, “Vlaams Gewest, 2060 Antwerpen,Lange Stuivenbergstraat 76-78” (deed in Dutch)
- Other provision, “info@thepharm.be, contactgegevens” (deed in Dutch)
- Director appointment, VINCENT DE MOOR (director)
- Power of attorney
- Capital
28-12
Gazette deed
Resignation: Demi-Demi BV (director)Appointment: Vincent De Moor BV (director) · Permanent representative: Vincent De Moor4 facts ▸
- General meeting, 28-09-2022
- Director resignation, Demi-Demi BV (director)
- Director appointment, Vincent De Moor BV (director)
- Permanent representative, Vincent De Moor
About the unread acts
Of the 9 Belgian Official Gazette deeds we know for this company, 3 have been read. The other 6 have not been read yet: what they contain is neither established nor disproved here.